Research teams from three academic institutions and two private sector companies on two continents have come together to form the "International Malaria Research Consortium for the development of novel classes of antimalarials", (the "Consortium") a bold initiative to develop novel classes of drugs against malaria, a deadly disease in desperate need of new treatments.
Toronto, ON - Each of the Consortium's five partners brings unique capabilities spanning the spectrum from academic research to commercial development ...
Satisfied Users & 
Approved Press Releases
